SCHEMBL22012866

SCHEMBL22012866

COC(=O)c1ccc([S+]([O-])Cl)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA12 O43570 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
XDH P47989 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 6/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 5/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5552196 0.81 HDAC1 (0.53) CA1CA2CA12CA7CA9
SCHEMBL29664708 0.76 CES2 (0.59) CA1CA2CA12CA7CA9
SCHEMBL14012582 0.76 CES2 (0.59) CA1CA2CA12CA7CA9
SCHEMBL383936 0.76 CES2 (0.59) CA1CA2CA12CA7CA9
SCHEMBL29825107 0.75 ALDH1A1 (0.58) CA1CA2CA12CA7CA9
SCHEMBL15968586 0.75 ALDH1A1 (0.58) CA1CA2CA12CA7CA9
SCHEMBL523320 0.73 KDM4E (0.62) CA1CA2CA12CA7CA9
SCHEMBL199239 0.73 CA1 (0.69) CA1CA2CA12CA7CA9
SCHEMBL2456384 0.73 CA1 (0.53) CA1CA2CA12CA7CA9
SCHEMBL1495863 0.73 HDAC1 (0.62) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102576-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed